Clinical and Regulatory Audits. Each of Dyax and Genzyme shall permit Kallikrein LLC and the other Party, or the representatives of Kallikrein LLC or the other Party, to have access during regular business hours and upon reasonable advance notice, at the auditing Party's own expense and no more than once in each calendar year during the term of this Agreement, to the non-auditing Party's records and facilities relating to the Development Program for the purpose of monitoring compliance with Good Clinical Practice and other applicable requirements of the Regulatory Scheme.
Appears in 4 contracts
Samples: Collaboration Agreement (Dyax Corp), Collaboration Agreement (Dyax Corp), Collaboration Agreement (Genzyme Corp)
